FRX Non-Approvable Letter for Social Anxiety Disorder Indication for Lexapro
Tweet Send to a Friend
Forest Laboratories, Inc. (NYSE: FRX) said the FDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
